Archives
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Translational Horizons: Mechanistic Insights and Strategi...
2025-10-06
This thought-leadership article explores the mechanistic underpinnings and strategic imperatives for translational oncology, spotlighting the L1023 Anti-Cancer Compound Library as an engine for high-throughput discovery. Anchored by emerging evidence on novel targets like PLAC1 and integrating lessons from recent studies, the article provides actionable guidance for researchers seeking to bridge the gap between molecular insight and clinical innovation in cancer therapeutics.
-
Epigenetic Precision in Translational Research: Leveragin...
2025-10-05
This thought-leadership article explores the transformative role of Trichostatin A (TSA) as a histone deacetylase inhibitor in bridging fundamental epigenetic mechanisms with translational applications. We examine the biological rationale, experimental advances, competitive landscape, and clinical implications of TSA, offering strategic guidance for researchers seeking to optimize organoid systems and cancer models. By integrating mechanistic insights and referencing recent breakthroughs in tunable organoid systems, the article provides a roadmap for harnessing TSA in scalable, high-throughput, and disease-relevant settings.
-
L1023 Anti-Cancer Compound Library: A Systems Pharmacolog...
2025-10-04
Explore how the L1023 Anti-Cancer Compound Library accelerates cancer research by empowering systems-level investigation of oncogenic pathways and molecular targets. This article reveals advanced, integrative strategies for high-throughput screening beyond conventional phenotypic assays.
-
Panobinostat (LBH589): HDAC Inhibition for Next-Gen Cance...
2025-10-03
Panobinostat (LBH589) stands out as a broad-spectrum HDAC inhibitor, enabling researchers to dissect novel apoptosis pathways beyond conventional transcriptional regulation. Its versatility accelerates studies in cancer resistance, epigenetic modulation, and targeted cell death mechanisms, offering distinct advantages for experimental design and troubleshooting.
-
Trichostatin A (TSA): Strategic Epigenetic Modulation for...
2025-10-02
Explore how Trichostatin A (TSA) is redefining the frontier of epigenetic regulation in cancer and organoid research. This thought-leadership article unpacks the mechanistic underpinnings, translational strategies, and future directions for leveraging HDAC inhibition to balance self-renewal and differentiation in next-generation organoid models.
-
Nicotinamide Riboside Chloride (NIAGEN): Advancing NAD+ M...
2025-10-01
Explore how Nicotinamide Riboside Chloride (NIAGEN) acts as a potent NAD+ metabolism enhancer and a transformative tool in metabolic dysfunction and neurodegenerative disease research. Dive into its unique mechanisms, latest applications, and its role in pioneering cellular energy homeostasis studies.
-
L1023 Anti-Cancer Compound Library: Precision Drug Discov...
2025-09-30
Explore how the L1023 Anti-Cancer Compound Library transforms cancer research with precision-targeted, cell-permeable compounds. Discover advanced strategies for biomarker-driven drug discovery and high-throughput screening of anti-cancer agents.
-
Panobinostat (LBH589): Decoding HDAC Inhibition and Apopt...
2025-09-29
Explore the multifaceted action of Panobinostat, a potent hydroxamic acid-based histone deacetylase inhibitor, in cancer epigenetics. This article uniquely dissects how Panobinostat orchestrates apoptosis induction in cancer cells through advanced epigenetic and mitochondrial crosstalk, integrating new mechanistic insights beyond chromatin remodeling.
-
L1023 Anti-Cancer Compound Library: Integrative Strategie...
2025-09-28
Discover how the L1023 Anti-Cancer Compound Library advances cancer research by enabling integrative, biomarker-driven discovery—specifically targeting novel molecules like PLAC1. Explore unique workflows that unite high-throughput screening and pathway analysis for next-generation oncology breakthroughs.
-
Trichostatin A (TSA): HDAC Inhibition for Precision Epige...
2025-09-27
Explore how Trichostatin A, a potent HDAC inhibitor, drives precision epigenetic regulation in advanced cancer and organoid research. Uncover novel insights into TSA’s molecular action and its transformative role in bridging cell fate control with therapeutic innovation.
-
Panobinostat (LBH589): Unraveling HDAC Inhibition and Mit...
2025-09-26
Discover how Panobinostat (LBH589), a broad-spectrum HDAC inhibitor, uniquely bridges histone acetylation and mitochondrial apoptosis pathways to overcome drug resistance in cancer cells. This article offers a novel analysis of LBH589’s mechanisms, integrating recent findings in epigenetic regulation research.
-
Genotyping Kit for Insects, Tissues, Fishes & Cells: Next...
2025-09-25
Explore how the Genotyping Kit for target alleles of insects, tissues, fishes and cells transforms rapid genomic DNA preparation and single-tube extraction for advanced molecular biology genotyping research. This article reveals a deeper mechanistic understanding and novel applications beyond standard protocols.
-
3X (DYKDDDDK) Peptide: Unveiling Novel Mechanisms in Orga...
2025-09-24
Explore the unique features of the 3X (DYKDDDDK) Peptide in organelle lipidomics, recombinant protein purification, and metal-dependent antibody interactions. This in-depth analysis reveals new frontiers for the 3X FLAG peptide in mitochondrial biology and protein engineering.
-
Cy3 TSA Fluorescence System Kit: Enhancing lncRNA Detecti...
2025-09-23
Explore how the Cy3 TSA Fluorescence System Kit advances detection of low-abundance biomolecules in cancer research, enabling precise analysis of lncRNA-mediated pathways. This article highlights technical strategies and scientific applications for next-generation signal amplification in immunohistochemistry.
-
Aurora A overexpression is also related to the activation
2025-04-22

Aurora-A overexpression is also related to the activation of NF-κB, a potent anti-apoptotic effector that may play a role in preventing apoptosis in cancer InstaBlue Protein Stain Solution [18]. These data show that we are still at the beginning of unraveling the complex mechanism by which these g
16474 records 8/1099 page Previous Next First page 上5页 678910 下5页 Last page